Development and Optimization of (111) In-Dinutuximab-IRDye800, a Dual-Modality Intraoperative Molecular Imaging Agent for Pediatric Neuroblastoma Resection.
Yip CY, Rosenblum LT, Pant A, Kahler-Quesada A, Chagantipati B, Sever R, Grano-Mickelsen B, Li B, Cortez AG, Latoche JD, Day KE, Rigatti L, Nedrow JR, Barry Edwards W, Kohanbash G, Malek MM
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.